MediPharm Labs Corp.
LABS.TO
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -6.32M | -5.96M | -5.78M | -6.26M | -5.42M |
| Total Depreciation and Amortization | 1.17M | 1.19M | 1.30M | 1.38M | 1.61M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 747.80K | 805.50K | 90.30K | 474.40K | 850.30K |
| Change in Net Operating Assets | 2.00M | 65.20K | -589.20K | -940.20K | -1.56M |
| Cash from Operations | -2.40M | -3.90M | -4.98M | -5.35M | -4.52M |
| Capital Expenditure | -42.70K | -71.30K | -102.70K | -115.30K | -125.80K |
| Sale of Property, Plant, and Equipment | 3.41M | 3.41M | 3.41M | 3.07M | 15.30K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 3.37M | 3.34M | 3.31M | 2.95M | -110.50K |
| Total Debt Issued | 500.00K | 500.00K | 500.00K | 550.00K | 799.00K |
| Total Debt Repaid | -611.00K | -692.00K | -806.00K | -2.98M | -3.05M |
| Issuance of Common Stock | -- | -- | 14.00K | 14.00K | 14.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 164.00K | 174.00K | 213.00K | 186.00K | 244.00K |
| Cash from Financing | 39.60K | -6.80K | -49.80K | -1.63M | -1.45M |
| Foreign Exchange rate Adjustments | 18.10K | 12.70K | 600.00 | 18.20K | 6.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.03M | -555.00K | -1.72M | -4.00M | -6.07M |